Expertise in
21
conditions

Dr. Harry Staszewski

Internal Medicine
North Shore Hematology Oncology Associates PC
49 Nesconset Hwy, 
Port Jefferson Station, NY 
Offers Telehealth
Expertise in
21
conditions
North Shore Hematology Oncology Associates PC
49 Nesconset Hwy, 
Port Jefferson Station, NY 

Overview

Harry Staszewski is a primary care provider, practicing in Internal Medicine in Port Jefferson Station, New York.

Dr. Staszewski is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Blood Clots, Familial Colorectal Cancer, Colorectal Cancer, and Hemochromatosis.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 3 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in NY

Hospital Affiliations

St Catherine Of Siena Hospital
John T Mather Memorial Hospital Of Port Jefferson

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Northwell Health
  • INSURANCE PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

North Shore Hematology Oncology Associates PC
49 Nesconset Hwy, Port Jefferson Station, NY 11776

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug, Other, Procedure
Study Drugs: Clofarabine, Daunorubicin, Cytarabine, Decitabine
Study Phase: Phase 3
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred
Enrollment Status: Terminated
Publish Date: November 06, 2024
Intervention Type: Drug
Study Drugs: SM-88, MPS (methoxsalen, phenytoin, sirolimus), Capecitabine, Gemcitabine, 5-FU
Study Phase: Phase 2/Phase 3
S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18(FACT-EGFRI 18) Questionnaire for EGFRI-Induced Skin Toxicities
S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18(FACT-EGFRI 18) Questionnaire for EGFRI-Induced Skin Toxicities
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Procedure
View 2 Less Clinical Trials

6 Total Publications

Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Journal: The oncologist
Published: July 27, 2023
Similar Doctors
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine

Radiology And Biomedical Imaging-New Haven-Yale Physicians Building

800 Howard Ave, 
New Haven, CT 
 (26.6 miles away)
203-785-7352
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pramod Mistry is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Mistry is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Gaucher Disease Type 3, Splenomegaly, and Splenectomy.

Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Before you request

Icahn School Of Medicine At Mount Sinai

5 E 98th St, 
New York, NY 
 (48.6 miles away)
212-241-9728
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Lebwohl is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Lebwohl is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP). Dr. Lebwohl is currently accepting new patients.

Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine
Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine

Office

1 Church St Ste 200, 
New Haven, CT 
 (27.0 miles away)
203-764-5885
Languages Spoken:
English
See accepted insurances

Harlan Krumholz is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Krumholz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Heart Attack, Heart Failure, Pulmonary Embolism, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Frequently Asked Questions about Dr. Harry Staszewski

How do I make an appointment with Dr. Harry Staszewski?

You can book an appointment with Dr. Harry Staszewski by calling their office at 631-751-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Harry Staszewski a top-rated expert for Blood Clots?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Harry Staszewski is classified as an Distinguished expert for Blood Clots, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Harry Staszewski specialize in?

While Dr. Harry Staszewski is a Internal Medicine, they have specific expertise in Blood Clots, Familial Colorectal Cancer, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Harry Staszewski participate in research or clinical trials?

Yes. Dr. Harry Staszewski has published 6 articles and abstracts on conditions like Blood Clots. You can view a list of Dr. Harry Staszewski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Harry Staszewski accept my insurance?

Dr. Harry Staszewski accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 631-751-3000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Staszewski's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 86 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile